A detailed history of Invesco Ltd. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Invesco Ltd. holds 527,694 shares of IRWD stock, worth $2.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
527,694
Previous 1,666,766 68.34%
Holding current value
$2.35 Million
Previous $10.9 Million 80.05%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$3.93 - $7.04 $4.48 Million - $8.02 Million
-1,139,072 Reduced 68.34%
527,694 $2.17 Million
Q2 2024

Aug 13, 2024

BUY
$5.58 - $8.61 $6.42 Million - $9.9 Million
1,149,803 Added 222.41%
1,666,766 $10.9 Million
Q1 2024

May 14, 2024

SELL
$8.32 - $15.45 $341,652 - $634,438
-41,064 Reduced 7.36%
516,963 $4.5 Million
Q4 2023

Feb 12, 2024

SELL
$8.79 - $11.51 $4.28 Million - $5.6 Million
-486,694 Reduced 46.59%
558,027 $6.38 Million
Q3 2023

Nov 13, 2023

SELL
$8.25 - $11.35 $5.13 Million - $7.06 Million
-622,111 Reduced 37.32%
1,044,721 $10.1 Million
Q2 2023

Aug 11, 2023

SELL
$10.1 - $11.6 $928,816 - $1.07 Million
-91,962 Reduced 5.23%
1,666,832 $17.7 Million
Q1 2023

May 12, 2023

BUY
$10.37 - $12.56 $576,406 - $698,135
55,584 Added 3.26%
1,758,794 $18.5 Million
Q4 2022

Feb 13, 2023

BUY
$9.9 - $12.43 $274,051 - $344,087
27,682 Added 1.65%
1,703,210 $21.1 Million
Q3 2022

Nov 14, 2022

BUY
$10.14 - $12.38 $4.72 Million - $5.76 Million
465,328 Added 38.45%
1,675,528 $17.4 Million
Q2 2022

Aug 15, 2022

BUY
$11.05 - $12.72 $5.85 Million - $6.74 Million
529,734 Added 77.85%
1,210,200 $14 Million
Q1 2022

May 16, 2022

SELL
$10.61 - $12.88 $867,006 - $1.05 Million
-81,716 Reduced 10.72%
680,466 $8.56 Million
Q4 2021

Feb 14, 2022

BUY
$10.86 - $13.95 $661,428 - $849,624
60,905 Added 8.68%
762,182 $8.89 Million
Q3 2021

Nov 15, 2021

SELL
$11.92 - $13.92 $154,054 - $179,902
-12,924 Reduced 1.81%
701,277 $9.16 Million
Q2 2021

Aug 17, 2021

SELL
$10.16 - $13.11 $2.16 Million - $2.78 Million
-212,325 Reduced 22.92%
714,201 $9.19 Million
Q1 2021

May 17, 2021

BUY
$9.04 - $11.86 $3.11 Million - $4.09 Million
344,567 Added 59.21%
926,526 $10.4 Million
Q4 2020

Feb 16, 2021

SELL
$9.05 - $12.2 $983,336 - $1.33 Million
-108,656 Reduced 15.73%
581,959 $6.63 Million
Q3 2020

Nov 16, 2020

SELL
$8.99 - $10.74 $653,599 - $780,830
-72,703 Reduced 9.52%
690,615 $6.21 Million
Q2 2020

Aug 14, 2020

BUY
$9.14 - $11.97 $1.58 Million - $2.07 Million
172,741 Added 29.25%
763,318 $7.88 Million
Q1 2020

May 15, 2020

BUY
$8.58 - $14.01 $4.63 Million - $7.56 Million
539,820 Added 1063.54%
590,577 $5.96 Million
Q4 2019

Feb 14, 2020

SELL
$8.22 - $14.0 $5.21 Million - $8.87 Million
-633,621 Reduced 92.58%
50,757 $676,000
Q3 2019

Nov 14, 2019

BUY
$8.59 - $10.96 $5.88 Million - $7.5 Million
684,378 New
684,378 $5.88 Million
Q2 2019

Aug 14, 2019

SELL
$9.8 - $12.89 $113,199 - $148,892
-11,551 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$8.27 - $12.73 $5,499 - $8,465
665 Added 6.11%
11,551 $156,000
Q4 2018

Feb 14, 2019

BUY
$7.8 - $16.13 $84,910 - $175,591
10,886 New
10,886 $113,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $682M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.